On November 27, 2025, CanSino Biologics Inc. (stock code: 6185) released an update on its Board of Directors, listing seven members in total. The Board includes Chairman and Executive Director, Dr. Xuefeng Yu, along with Executive Directors, Dr. Shou Bai Chao and Ms. Jing Wang, Non-executive Director, Mr. Chi Shing Li, and three Independent Non-executive Directors: Mr. Yiu Leung Andy Cheung, Mr. Man Cho, and Ms. Xuefeng Ji.

Committee assignments were also disclosed. Dr. Yu serves on both the Audit Committee and the Remuneration and Assessment Committee. Mr. Li likewise holds membership in those two committees. Mr. Cheung chairs the Audit Committee and is a member of the Remuneration and Assessment Committee, while Mr. Cho chairs the Remuneration and Assessment Committee and is a member of the Nomination Committee. Ms. Ji serves as a member of the Audit and Remuneration and Assessment Committees and chairs the Nomination Committee.